Stryker Total Current Liabilities 2010-2025 | SYK
Stryker total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Stryker total current liabilities for the quarter ending March 31, 2025 were $7.929B, a 14% increase year-over-year.
- Stryker total current liabilities for 2024 were $7.616B, a 3.85% decline from 2023.
- Stryker total current liabilities for 2023 were $7.921B, a 25.67% increase from 2022.
- Stryker total current liabilities for 2022 were $6.303B, a 38.56% increase from 2021.
| Stryker Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $7,616 |
| 2023 | $7,921 |
| 2022 | $6,303 |
| 2021 | $4,549 |
| 2020 | $5,041 |
| 2019 | $4,400 |
| 2018 | $4,807 |
| 2017 | $3,485 |
| 2016 | $3,148 |
| 2015 | $3,502 |
| 2014 | $4,461 |
| 2013 | $2,657 |
| 2012 | $1,876 |
| 2011 | $1,840 |
| 2010 | $1,605 |
| 2009 | $1,441 |
| Stryker Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $7,929 |
| 2024-12-31 | $7,616 |
| 2024-09-30 | $7,669 |
| 2024-06-30 | $6,926 |
| 2024-03-31 | $6,955 |
| 2023-12-31 | $7,921 |
| 2023-09-30 | $7,458 |
| 2023-06-30 | $6,584 |
| 2023-03-31 | $5,866 |
| 2022-12-31 | $6,303 |
| 2022-09-30 | $4,571 |
| 2022-06-30 | $4,404 |
| 2022-03-31 | $4,408 |
| 2021-12-31 | $4,549 |
| 2021-09-30 | $4,449 |
| 2021-06-30 | $4,252 |
| 2021-03-31 | $3,953 |
| 2020-12-31 | $5,041 |
| 2020-09-30 | $4,689 |
| 2020-06-30 | $4,405 |
| 2020-03-31 | $4,162 |
| 2019-12-31 | $4,400 |
| 2019-09-30 | $3,921 |
| 2019-06-30 | $3,946 |
| 2019-03-31 | $3,713 |
| 2018-12-31 | $4,807 |
| 2018-09-30 | $4,153 |
| 2018-06-30 | $4,046 |
| 2018-03-31 | $4,800 |
| 2017-12-31 | $3,485 |
| 2017-09-30 | $3,258 |
| 2017-06-30 | $3,552 |
| 2017-03-31 | $2,554 |
| 2016-12-31 | $3,148 |
| 2016-09-30 | $3,026 |
| 2016-06-30 | $3,605 |
| 2016-03-31 | $3,186 |
| 2015-12-31 | $3,502 |
| 2015-09-30 | $3,553 |
| 2015-06-30 | $3,723 |
| 2015-03-31 | $3,695 |
| 2014-12-31 | $4,461 |
| 2014-09-30 | $4,211 |
| 2014-06-30 | $3,713 |
| 2014-03-31 | $3,558 |
| 2013-12-31 | $2,657 |
| 2013-09-30 | $2,324 |
| 2013-06-30 | $1,971 |
| 2013-03-31 | $1,808 |
| 2012-12-31 | $1,876 |
| 2012-09-30 | $1,576 |
| 2012-06-30 | $1,489 |
| 2012-03-31 | $1,549 |
| 2011-12-31 | $1,840 |
| 2011-09-30 | $1,562 |
| 2011-06-30 | $1,604 |
| 2011-03-31 | $1,587 |
| 2010-12-31 | $1,605 |
| 2010-09-30 | $1,406 |
| 2010-06-30 | $1,295 |
| 2010-03-31 | $1,405 |
| 2009-12-31 | $1,441 |
| 2009-09-30 | $1,198 |
| 2009-06-30 | $1,075 |
| 2009-03-31 | $1,182 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $149.817B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Medtronic (MDT) | Ireland | $112.441B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Insulet (PODD) | United States | $21.162B | 83.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| Neogen (NEOG) | United States | $1.081B | 13.83 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Owens & Minor (OMI) | United States | $0.669B | 5.55 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |